These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12505694)

  • 21. Development of a novel class of monocyclic and bicyclic alkyl amides that exhibit CB1 and CB2 cannabinoid receptor affinity and receptor activation.
    Berglund BA; Fleming PR; Rice KC; Shim JY; Welsh WJ; Howlett AC
    Drug Des Discov; 2000; 16(4):281-94. PubMed ID: 10807034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An invertebrate G-protein coupled receptor is a chimeric cannabinoid/melanocortin receptor.
    Elphick MR
    Brain Res; 1998 Jan; 780(1):170-3. PubMed ID: 9497095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential superactivation of adenylyl cyclase isozymes after chronic activation of the CB(1) cannabinoid receptor.
    Rhee MH; Nevo I; Avidor-Reiss T; Levy R; Vogel Z
    Mol Pharmacol; 2000 Apr; 57(4):746-52. PubMed ID: 10727521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of structural analogs of prostaglandin amides for binding to and activation of CB1 and CB2 cannabinoid receptors in rat brain and human tonsils.
    Berglund BA; Boring DL; Howlett AC
    Adv Exp Med Biol; 1999; 469():527-33. PubMed ID: 10667378
    [No Abstract]   [Full Text] [Related]  

  • 25. Structural requirements for arachidonylethanolamide interaction with CB1 and CB2 cannabinoid receptors: pharmacology of the carbonyl and ethanolamide groups.
    Berglund BA; Boring DL; Wilken GH; Makriyannis A; Howlett AC; Lin S
    Prostaglandins Leukot Essent Fatty Acids; 1998 Aug; 59(2):111-8. PubMed ID: 9774174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes.
    Savinainen JR; Järvinen T; Laine K; Laitinen JT
    Br J Pharmacol; 2001 Oct; 134(3):664-72. PubMed ID: 11588122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of G-proteins in brain by endogenous and exogenous cannabinoids.
    Childers SR
    AAPS J; 2006 Mar; 8(1):E112-7. PubMed ID: 16584117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of cannabinoid receptors in cultures of rat cerebellar granule cells.
    Pacheco MA; Ward SJ; Childers SR
    Brain Res; 1993 Feb; 603(1):102-10. PubMed ID: 8384043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview.
    Basavarajappa BS; Hungund BL
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):287-99. PubMed ID: 12052043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction.
    Felder CC; Briley EM; Axelrod J; Simpson JT; Mackie K; Devane WA
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7656-60. PubMed ID: 8395053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CB1 receptor-G protein association. Subtype selectivity is determined by distinct intracellular domains.
    Mukhopadhyay S; Howlett AC
    Eur J Biochem; 2001 Feb; 268(3):499-505. PubMed ID: 11168387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
    Felder CC; Joyce KE; Briley EM; Mansouri J; Mackie K; Blond O; Lai Y; Ma AL; Mitchell RL
    Mol Pharmacol; 1995 Sep; 48(3):443-50. PubMed ID: 7565624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A mutation in the second transmembrane region of the CB1 receptor selectively disrupts G protein signaling and prevents receptor internalization.
    Roche JP; Bounds S; Brown S; Mackie K
    Mol Pharmacol; 1999 Sep; 56(3):611-8. PubMed ID: 10462549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of extracellular signal-regulated kinase activation by the CB(1) cannabinoid receptor.
    Galve-Roperh I; Rueda D; Gómez del Pulgar T; Velasco G; Guzmán M
    Mol Pharmacol; 2002 Dec; 62(6):1385-92. PubMed ID: 12435806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The CB(1) cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein fan.
    Sánchez C; Rueda D; Ségui B; Galve-Roperh I; Levade T; Guzmán M
    Mol Pharmacol; 2001 May; 59(5):955-9. PubMed ID: 11306675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxyl ic acid phenylamide (CP-272871) for the CB(1) cannabinoid receptor.
    Meschler JP; Kraichely DM; Wilken GH; Howlett AC
    Biochem Pharmacol; 2000 Nov; 60(9):1315-23. PubMed ID: 11008125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling.
    Molina-Holgado E; Vela JM; Arévalo-Martín A; Almazán G; Molina-Holgado F; Borrell J; Guaza C
    J Neurosci; 2002 Nov; 22(22):9742-53. PubMed ID: 12427829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Signaling pathways involved in the development of cannabinoid tolerance.
    Martin BR; Sim-Selley LJ; Selley DE
    Trends Pharmacol Sci; 2004 Jun; 25(6):325-30. PubMed ID: 15165748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functionally selective cannabinoid receptor signalling: therapeutic implications and opportunities.
    Bosier B; Muccioli GG; Hermans E; Lambert DM
    Biochem Pharmacol; 2010 Jul; 80(1):1-12. PubMed ID: 20206137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Independence of, and interactions between, cannabinoid and opioid signal transduction pathways in N18TG2 cells.
    Shapira M; Gafni M; Sarne Y
    Brain Res; 1998 Sep; 806(1):26-35. PubMed ID: 9739102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.